102 related articles for article (PubMed ID: 3262196)
21. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
22. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
[TBL] [Abstract][Full Text] [Related]
23. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
24. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
Fernandez HN; Hugli TE
J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
[TBL] [Abstract][Full Text] [Related]
25. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the receptor for C4a is distinct from the C3a receptor.
Ames RS; Tornetta MA; Foley JJ; Hugli TE; Sarau HM
Immunopharmacology; 1997 Dec; 38(1-2):87-92. PubMed ID: 9476119
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
Wagner JL; Hugli TE
Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
[TBL] [Abstract][Full Text] [Related]
28. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
[TBL] [Abstract][Full Text] [Related]
29. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
Ohkohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
31. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Fernandez HN; Hugli TE
J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
[TBL] [Abstract][Full Text] [Related]
32. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
[TBL] [Abstract][Full Text] [Related]
33. Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement.
Kato Y; Nakao M; Shimizu M; Wariishi H; Yano T
Dev Comp Immunol; 2004 Jul; 28(9):901-10. PubMed ID: 15183031
[TBL] [Abstract][Full Text] [Related]
34. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
35. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
36. Inability of rat anaphylatoxin to induce histamine release in rats.
Konno S; Tsurufuji S
Jpn J Pharmacol; 1985 Jun; 38(2):185-93. PubMed ID: 2411984
[TBL] [Abstract][Full Text] [Related]
37. Proteins separated from human IgG molecules.
Nezlin R; Freywald A; Oppermann M
Mol Immunol; 1993 Jul; 30(10):935-40. PubMed ID: 8341284
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
39. The purification and characterization of bovine C4, the fourth component of complement.
Booth NA; Campbell RD; Fothergill JE
Biochem J; 1979 Mar; 177(3):959-65. PubMed ID: 312644
[TBL] [Abstract][Full Text] [Related]
40. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Chenoweth DE; Cheung AK; Henderson LW
Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
